Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Lument Finance Trust reported its third quarter 2026 financial results, posting a GAAP net loss of $13.5 million, or $2.57 per share. The company also reported a non-GAAP Distributable Loss of $0.7 million, or $0.13 per share, for the period ended September 30, 2026.
Epr Properties $575M Debt Financing with U.S. Bank Trust Company, National Association
EPR Properties closed a private offering of $575.0 million in 4.5% Convertible Senior Notes due 2032, which included the full exercise of a $75.0 million overallotment option. The company used the proceeds to fund capped call transactions, repurchase $50.0 million of its common shares, and intends to repay $450.0 million of existing 4.750% Senior Notes maturing in December 2026.
Moderna $900M Debt Financing with Ares Capital Corporation
Moderna entered into an amendment to its existing Credit and Guaranty Agreement with Ares Capital Corporation, reducing interest rate margins by 0.75 percentage points and extending the maturity date to November 24, 2031. The amendment also extends the availability period for $900 million in delayed draw term loan commitments through November 2029.
Metech Group Inc. reported a significant increase in net income to $1,083,316 for the nine months ended September 30, 2026, compared to $501,013 in the prior year period, driven by a 18.4% growth in revenues. The company successfully alleviated its going concern doubt due to recent profitability and financial support from significant shareholders.
Stark Novus Financial Inc. reported a net loss of $2.5 million for the quarter ended September 30, 2026, as it transitioned into insurance and wealth management services following its reorganization. The company's balance sheet shows a shift from a positive stockholders' equity of $2.6 million at the end of 2025 to a deficit of $2.3 million by September 2026.
Limitless X Holdings Inc. reported a significant decline in net revenue to $143,399 for the nine months ended September 30, 2026, compared to $802,396 in the prior year. The company incurred a net loss of $34,096,665 during this period, driven largely by a $27.8 million loss on the conversion of Preferred C to Preferred D stock and high salary expenses.
Feel The World, Inc. reported a significant turnaround for the nine months ended September 30, 2026, with net income of $2.15 million compared to a net loss of $1.91 million in the prior year period. Revenue grew to $50.69 million, driven by improved gross margins and operational efficiencies, despite an accumulated deficit of $4.28 million.
TruGolf Holdings reported a net loss of $3.98 million for the nine months ended September 30, 2026, a significant improvement from the $13.27 million loss in the prior year period. Revenue grew 16.8% to $16.13 million, while the company's stockholders' equity shifted to a deficit of $22,716 as of the end of the quarter.
Tevogen Inc. reported a net loss of $18.2 million for the nine months ended September 30, 2026, compared to $21.6 million in the prior year period. The company continues to operate with a significant stockholders' deficit of $11.3 million and relies on financing activities, including a $3.0 million loan and $3.0 million from pre-funded warrants, to fund its biotechnology and AI initiatives.
Lightstone Value Plus REIT III reported a net loss of $7.2 million for the nine months ended September 30, 2026, compared to a $3.3 million loss in the prior year, primarily driven by a $4.6 million impairment charge. Total assets decreased to $110.8 million from $117.2 million at year-end 2025, while total equity declined to $46.7 million due to the net loss and share redemptions.
Integrated Rail & Resources Inc. reported a net income of $685,749 for the nine months ended September 30, 2026, a significant recovery from a net loss of $5,562,621 in the prior year period, primarily driven by a $5.8 million gain from the change in fair value of warrant liabilities. Despite the net profit, the company maintains a stockholders' deficit of $16.2 million and notes substantial doubt about its ability to continue as a going concern as it works toward a 2028 facility in-service date.
Beneficient reported a net loss of $39.4 million for the quarter ended September 30, 2026, compared to a loss of $17.9 million in the prior year period. Total assets decreased to $227.3 million from $238.8 million at fiscal year-end, while the company's accumulated deficit grew to $2.12 billion.
Vivos Therapeutics is transitioning from a legacy dentist-focused model to a medical-provider focused sales and distribution model, highlighted by the acquisition of The Sleep Center of Nevada and a transaction with SOD Sciences. The company faces significant challenges regarding its Nasdaq listing requirements and the integration of its new business model while managing substantial indebtedness.
For the nine months ended September 30, 2026, Global Macro Trust reported a significant turnaround with a net income of $8,596,407 compared to a net loss of $3,561,629 in the prior year period. This performance was driven by $9,247,519 in total net realized and unrealized gains, primarily from futures and forward currency contracts, which offset a net investment loss of $636,505.
Super League Enterprise reported a net loss of $11.3 million for the nine months ended September 30, 2026, compared to $10.6 million in the prior year period, despite a 6% increase in revenue to $8.6 million. The company's balance sheet shows a significant decrease in cash and cash equivalents from $14.4 million at year-end 2025 to $4.4 million as of September 30, 2026.
Mangoceuticals, Inc. is a smaller reporting company and emerging growth company focused on scaling its operations and marketing its products. The filing highlights significant risks including a limited operating history, the need for additional funding, and reliance on third-party compounding pharmacies for products not approved by the FDA.
CDT Equity Inc. reported a net loss of $13.3 million for the nine months ended September 30, 2026, compared to $17.9 million in the prior year. The company significantly expanded its balance sheet through a $153.5 million equity method investment, resulting in total assets increasing from $5.7 million to $158.7 million.
BluSky AI Inc. reported a net loss of $1,476,476 for the nine months ended September 30, 2026, compared to a net loss of $4,014,763 in the prior year period. The company remains in a stockholders' deficit position of $787,655, though it successfully raised $1,910,966 through common stock issuances during the period.
Longduoduo Co Ltd reported a significant revenue decline to $17,595 for the quarter ended September 30, 2026, compared to $658,764 in the prior year, primarily due to a sharp drop in commission revenue. The company realized a net loss of $474,167 for the period and underwent a corporate restructuring involving the deregistration of its Hong Kong subsidiary.
Adi Global Distribution Executive VP and CMO Marco Cardazzi Buys $25.1K of Stock
Marco Cardazzi, Executive VP and CMO, bought 2,508 shares of Adi Global Distribution Inc. at $10.00 a share, worth $25.1K in total on Nov 13, 2026. Shares held after the trade: 12,917 (+24.1%).
Adi Global Distribution President and CEO Robert B. Aarnes Buys $100K of Stock
Robert B. Aarnes, President and CEO, bought 10,073 shares of Adi Global Distribution Inc. at $9.93 a share, worth $100K in total on Nov 13, 2026. Shares held after the trade: 123,721 (+8.9%).
Adi Global Distribution Exec. VP, GC, Corp. Sec. & CCO Jeannine J. Lane Buys $50.1K of Stock
Jeannine J. Lane, Exec. VP, GC, Corp. Sec. & CCO, bought 5,241 shares of Adi Global Distribution Inc. at $9.55 a share, worth $50.1K in total on Nov 16, 2026. Shares held after the trade: 86,133 (+6.5%).
Adi Global Distribution Executive VP, CFO Michael Carlet Buys $99.9K of Stock
Michael Carlet, Executive VP, CFO, bought 10,288 shares of Adi Global Distribution Inc. at $9.71 a share, worth $99.9K in total on Nov 13, 2026. Shares held after the trade: 50,623 (+25.5%).
Covenant Logistics Group Chairman and CEO David Ray Parker Sells $5.66M of Stock
David Ray Parker, Chairman and CEO, sold 173,989 shares of Covenant Logistics Group, Inc. at $32.35 to $33.77 a share (average $32.54) in 4 transactions, worth $5.66M in total between Nov 12, 2026 and Nov 16, 2026. Shares held after the trade: 1,803,555 (-4.7%).
SDR Drone, Inc. reported a net loss of $598,438 for the nine months ended September 30, 2026, compared to a loss of $760,649 in the prior year period. The company remains in a development stage with zero revenue and a stockholders' deficit of $243,944, primarily driven by professional fees and non-cash expenses related to debt amortization and derivative liabilities.
For the nine months ended September 30, 2026, ConnectM Technology Solutions reported revenues of $26.35 million, an increase from $24.31 million in the prior year. The company recorded a net loss attributable to stockholders of $2.32 million, significantly improved from a $12.18 million loss in 2025, primarily due to a $19.05 million gain on the disposal of discontinued operations.
Host Digital Inc. reported a net loss of $11.45 million for the eight months ended September 30, 2026, following a reverse acquisition and public offering in September 2026. The company generated $1.48 million in net sales during the period, while significantly expanding its balance sheet to $108.2 million in total assets, primarily through intangible assets and right-of-use assets.
Picard Medical, Inc. is a newly public medical device company focused on total artificial heart therapy, reporting 2,661,574 shares outstanding as of November 12, 2026. The filing highlights significant risks including customer concentration, reliance on single-source suppliers, and an explanatory paragraph from its auditors regarding its ability to continue as a going concern.
Cyabra, Inc. reported revenues of $5.27 million for the nine months ended September 30, 2026, compared to $4.08 million in the prior year period. The company experienced a significant net loss of $16.8 million, driven by increased research and development and general administrative expenses following a business combination and PIPE financing.
Omeros reported strong Yard-Temlia momentum with $35.9M net sales and positive operating cash flow, though European regulatory setbacks and a refusal to provide 2027 guidance remain key overhangs.